These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3312799)

  • 21. [Maintaining the full benefit of statins. Therapy start 10 years earlier?].
    MMW Fortschr Med; 2002 Aug; 144(33-34):55. PubMed ID: 12380149
    [No Abstract]   [Full Text] [Related]  

  • 22. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Watts GF; Shaw JE; Pang J; Magliano DJ; Jennings GL; Carrington MJ
    Int J Cardiol; 2015 Apr; 185():69-71. PubMed ID: 25791093
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 26. Current perspectives on statins.
    Mishra TK; Routray S
    J Indian Med Assoc; 2003 Jun; 101(6):381-3. PubMed ID: 14579987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases.
    Kajinami K; Kasashima S; Oda Y; Koizumi J; Katsuda S; Mabuchi H
    Mod Pathol; 1999 Dec; 12(12):1174-80. PubMed ID: 10619272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statement for Appropriate Clinical Use of PCSK9 Inhibitors.
    Nohara A; Ohmura H; Okazaki H; Ogura M; Kitagawa K; Koseki M; Sato K; Tsukamoto K; Yamashita S;
    J Atheroscler Thromb; 2018 Aug; 25(8):747-750. PubMed ID: 29899173
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypercholesterolaemia in children guidelines review.
    Baumer JH; Shield JP
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):84-6. PubMed ID: 19460897
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial hypercholesterolemia].
    Heinzl S
    Med Monatsschr Pharm; 1987 Dec; 10(12):381-7. PubMed ID: 3325786
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 33. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy of severe hypercholesterolemia.
    Weizel A; Richter WO
    Eur J Med Res; 1997 Jun; 2(6):265-9. PubMed ID: 9182654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Approved indication for Ezetrol].
    Eriksson N; Phillipson T
    Lakartidningen; 2005 Mar 14-20; 102(11):887. PubMed ID: 15835530
    [No Abstract]   [Full Text] [Related]  

  • 36. Goals for cholesterol lowering.
    Stankler L
    Circulation; 1999 May; 99(18):2477. PubMed ID: 10318741
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal lipids, statins, and dementia.
    Lavie CJ; Milani RV
    J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
    Banz H; Gall FP
    Med Klin; 1980 Jan; 75(1):35-6. PubMed ID: 7366519
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia.
    van Wissen S; Smilde TJ; Trip MD; Stalenhoef AF; Kastelein JJ
    Am J Cardiol; 2005 Jan; 95(2):264-6. PubMed ID: 15642565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.